Zoetis Inc. Equity-NMS: ZTS

Healthcare

Drug Manufacturers - Specialty & Generic

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$126.41
Open :	$126.04
Today's high :	$126.84
Today's low :	$125.77
1Y :	-23.43%
5Y :	-23.7%

What is the share price of Zoetis Inc. today?

Zoetis Inc. (ZTS) share price as of January 2, 2026, is $125.82. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Zoetis Inc.?

Yes, Indian Investors can invest in the Zoetis Inc. (ZTS) Share by opening an international trading account with Angel One.

How can I purchase Zoetis Inc. shares in India?

Purchasing Zoetis Inc. (ZTS) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Zoetis Inc. (ZTS) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Zoetis Inc.?

Yes, you can purchase fractional shares of Zoetis Inc. (ZTS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Zoetis Inc.?

The market capitalization of Zoetis Inc. on January 2, 2026, is $0.

In which sector Zoetis Inc. belongs?

Zoetis Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

What documents are required to invest in Zoetis Inc. stocks?

In order to invest in Zoetis Inc. (ZTS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).